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Abstract
The opioid epidemic is an ongoing health crisis in the United States, claiming the
lives of thousands over the past two decades. In 2014, provisions of the Affordable Care
Act expanding Medicaid officially came in effect, extending healthcare to millions of
people in the United States. However, Medicaid expansion was optional for states, so
some states greatly expanded healthcare to low-income people while others did not.
People in expansion states gained more affordable access to prescription drugs and
treatment centers, making opioids easier to obtain and addictions more affordable to
treat. This makes the effect of the Affordable Care Act on the opioid epidemic
ambiguous, since it could either help or worsen the crisis, depending on if easier access
to opioids or treatment has a larger effect on overdoses. In this paper, I use a
difference-in-differences approach using state-level data from 2008 to 2019 to compare
Opioid overdose death rates between expansion states and non-expansion states. I find
significant evidence that Medicaid expansion is correlated with an increase in Opioid
overdose deaths.
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Introduction
The opioid epidemic in the United States has been raging since the late nineties.
Many patients were unaware of the addictive and dangerous nature of opioids, leading
to many addictions and deaths. Since 1999, over 500,000 individuals have died from
opioid abuse, with around 68,000 deaths coming in 2020 alone, making up about 75%
of all overdose deaths (CDC, 2022). In this paper I examine the roots of the opioid
epidemic. I explore if increased access to care has led to an increase in opioid-related
deaths in recent years. Most opioid deaths, about 80%, come from dangerous, synthetic
opioids that are not prescribed to the individual but, instead, are stolen or bought on the
black market without the guidance of a doctor (CDC, 2022). There is also a risk of
secondary addictions to other hard drugs which frequently cause misuse and death, like
heroin or methamphetamines (CDC, 2022). However, most addictions begin with initial
prescriptions under medical guidance that turn into long-term dependence (Mayo
Foundation for Medical Education and Research, 2022). Increased coverage lowers the
cost of doctor visits and medicinal pain relief and, thereby, leads to increased opioid
availability. Increased availability leads to more use, which can cause more addictions
over time. Addiction to opioids can eventually lead to overdose, or further addiction to
more dangerous drugs which eventually lead to overdose and death. There is also
potential for riskier use resulting from increased availability of treatment as people use
available treatment as a crutch, leading to more overdose deaths. These facts raise the
question if policy decisions that increase the availability of health insurance have a
negative effect on opioid overdoses.
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In 2010, President Barack Obama signed into law the Affordable Care Act, which
made healthcare coverage accessible for over 20 million Americans and reduced the
uninsured population by nearly 50 percent (US Department of Health and Human
Services, 2021). Most provisions of the act came into effect in 2014, increasing the
availability of opioids but also increasing the availability of addiction treatment options
(US Department of Health and Human Services, 2021). Therefore, it is not obvious what
kind of effect the act would have on the opioid crisis since it introduces easier access to
opioids but also easier access to treatment options to prevent opioid deaths. This paper
uses the Affordable Care Act as a treatment in a difference-in-differences method, with
states that have not adopted the Affordable Care Act acting as a control group. The
results find that opioid overdose deaths increased significantly after the implementation
of the Affordable Care Act in 2014, with the effects of the act not showing until a few
years after implementation.
Literature Review
Previous literature on the opioid crisis as it relates to healthcare is extensive. The
focus of previous papers has been on the relationship between access to care and
opioid overdoses as well as overall mortality. The Affordable Care Act and naloxone
access, among others, are used as treatments in difference-in-differences models.
Other papers look at how opioid treatment facilities are utilized after expanding
Medicaid to see if the policy changes lead to higher treatment utilization. There is also
extensive research on the relationship between the legalization of medical marijuana
and opioid overdoses to be discussed later in the section.
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Averett, Smith, and Wang (2019) examine the relationship between healthcare
coverage and opioid overdoses. They use the implementation of the Affordable Care
Act (ACA) as a treatment, just as I will. A difference-in-differences model was used to
see if there was a significant increase in opioid-related deaths after more people
received healthcare coverage because of the ACA. States included in the treatment
group adopted the Medicaid expansion in 2014 when the act was initially passed. States
that implemented the act after or before 2014 are not included in the analysis, and
states that never adopted the Medicaid expansion (in the time frame of the paper, so,
pre-2017) are used as a control group. In the paper they control for the minimum wage,
food insecurity, demographics, etc. as well as the availability of medical marijuana,
naloxone access, and prescription drug monitoring programs. They find an increase in
opioid overdose deaths after the Affordable Care Act was implemented, but insufficient
evidence to definitively say this was a non-zero, significant increase.
Black, Hollingsworth, Nunes, and Simon (2019) analyze the relationship between
health insurance and overall mortality, also using the ACA as a treatment in a
difference-in-differences model. Since there was a considerable rise in mortality in nonexpansion states compared with expansion states in the years leading up to the
Affordable Care Act, it was difficult to account for this in a difference-in-differences
model. They use several models, triple difference, and synthetic control approaches, but
are unable to produce explanatory power because of the rise in mortality in the control
group. This made them unable to pinpoint the exact relationship between the expansion
of Medicaid and overall mortality on a causal level, as their results could be interpreted
as expanding Medicaid having no effect on mortality or having a large effect on
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mortality, leaving an ambiguous conclusion to be explored by future research. They also
use power analysis to conduct a simulation, but this is still unable to produce a definite
causal relationship with the given data provided by the real-life experiment of the
Affordable Care Act. Data from a longer time span and more specific causes of
mortality are needed to establish a definite and significant relationship between health
insurance and mortality.
Meinhofer and Witman (2018) use state by state data from the Affordable Care
Act to examine the relationship between health insurance and the treatment of opioid
use disorders. Their method was using a difference in differences design to compare
the utilization of opioid treatment centers before and after the expansion of Medicaid
across states. They found that utilization of these facilities increased considerably when
Medicaid was expanded to more people without crowding out patients with existing
health insurance, implying that there may be a benefit to expanding healthcare
coverage to combat the opioid crisis, as people utilize the resources provided by
expanding Medicaid at a higher rate than before the expansion of Medicaid. This
increase in utilization appears to be driven by increases in medication-assistedtreatment providers and greater acceptance of Medicaid payments by existing
providers.
There have also been indications that expanding access to treatment options can
increase opioid-related incidents and in some cases, mortality. Doleac and Mukherjee
(2018) examine the effect of naloxone access on different health outcomes like opioidrelated emergency room visits, overdoses, and mortality, as well as outcomes on crime
and other drug-related issues. They find that having greater access to treatment
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options, in this case naloxone, has several effects on different outcomes that would
indicate moral hazard associated with greater access to healthcare. Some of those
outcomes are an increase in opioid-related hospital visits, an increase in theft to finance
opioid addictions, and a potential increase in the use of fentanyl, a particularly
dangerous synthetic opioid, which contributes to a significant number of deaths in the
United States every year. This shows some potential moral hazard present when
healthcare access is expanded, as it may lead to greater mortality.
There has also been work done on the relationship between the legalization of
medical marijuana and the utilization of opioids. To examine the relationship Shah et al
(2018) obtain a sample of commercially insured people in the United States and get
data on opioid use, chronic use, and high-risk use, controlling for patient, year, and
state-level factors. They used a multilevel logistic regression analysis to find the effect
of the legalization of medical marijuana on the three opioid measures. Legalization of
marijuana significantly reduced the odds of any opioid use including normal use and
chronic use (Shah et al., 2018). It also reduced the number of opioids prescribed by
doctors. Marijuana may have a positive effect in helping alleviate the opioid crisis.
I will add to existing literature by using a wider time frame while following a model
similar to Averett, Smith, and Wang (2019), since the Affordable Care Act has been
available for several years now, allowing for more precise estimates and more treated
observations. I also expand the data to 2008 rather than 2010 for more observations. I
focus on Opioid overdose mortality rather than overall mortality, to avoid the problems
faced by Black, Hollingsworth, Nunes, and Simon (2019). I attempt to either confirm or
call into question the findings of previous literature, where I find that when using an
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extended data frame, the Affordable Care Act appears to increase opioid-related
mortality, a different finding from Averett, Smith, and Wang (2019).
DATA
The data come from a variety of sources to account for the political, economic, and
medical factors that go into healthcare coverage and opioid overdoses in different
states. The main response variable of interest is the age-adjusted opioid overdose
death rate per one-hundred thousand people in a state. The age-adjusted rate uses the
2000 U.S. standard population to allow for comparison between states that have
different age structures. Data for the variable come from the CDC wonder website’s
ICD-10 multiple cause of death data using death codes X40-44, X60-64, X85, and Y1014, which covers opioid related deaths of all intents. The percentage of people without
health insurance by state comes from the Current Population Survey Annual Social and
Economic Supplement (CPS ASEC) HIC tables, provided by the U.S. Census Bureau.
Economic controls included in the model are the unemployment rate, median household
income (in US dollars), and the percentage of people in the state with a high school
diploma. These variables were obtained from the Bureau of Labor Statistics, the St
Louis Federal Reserve Economic Data, and the U.S. Census Bureau American
Community Survey Educational Attainment data, respectively. Demographic variables
including the percentages of white, black, and Hispanic people as well as the
percentage of people aged 18 to 25 in each state are included as well, obtained from
the Kaiser Family Foundation’s 1-year estimates from the U.S. Census Bureau
American Community Survey. This paper also controls for states that have passed a
medical marijuana access law using a dummy variable, attained from state-by-state
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medical marijuana data at procon.org. Information on Medicaid expansion status by
state was obtained from KFF’s status of state Medicaid decisions interactive map. All
data are from the years 2008 to 2019.
Summary statistics for each group of states can be found in Table 1. Many of the
trends shown before and after ACA implementation are similar for expansion and nonexpansion states, like decreased unemployment and percentage of people aged 18 to
24 as well as increased median household income and percentage of people with a
high school diploma. Demographic variables remain similar, with both groups showing
an increase in the Hispanic population and a decrease in the white population. Both
groups also show an increase in overdose deaths per 100,000, but the expansion states
have a much larger increase. There is also a large difference between the two groups in
the implementation of medical marijuana laws, which are implemented at a much higher
rate in expansion states. The similarities in data trends suggest that non-expansion and
expansion states are good comparison groups, since they have similar trends in most
independent variables before and after ACA expansion. Figure 1 shows the similarities
in overdose trends prior to the expansion and the divergence in overdoses occurring
after the expansion of Medicaid.
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Table 1: Summary Statistics for Expansion and Non-Expansion States Before and
After Medicaid Expansion

Figure 1: Overdose Deaths Over Time for Expansion vs. Non-Expansion States
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Methods
The main method used in this paper is a difference-in-differences model, shown
below, which will assess the effect of Medicaid expansion on opioid overdose deaths:
yst = b0+b1Expansion*Post + b2C + ds + tt + est
where yst is the log of the opioid overdose death rate per 100k adjusted for age by
state. C includes all controls mentioned previously, while ds and tt represent state and
year fixed effects, respectively, while est is an error term. States that expanded Medicaid
in 2014 are assigned to the treatment group, while states that adopted the Medicaid
expansion at a different time are dropped from the analysis for simplicity purposes
(states included in the treatment and control groups are shown in Table 2). States that
have not adopted the Medicaid expansion are assigned to the control group. The preexpansion period is defined as before 2014 and is assigned a value of 0. The postexpansion period is 2014 and after, assigned a value of 1. Standard errors are clustered
by state. I also present a regression showing the differences between the treatment and
control groups by year using a year*expansion interaction variable, shown below:
yst = b0+b1Year*Expansion + b2C + ds + est
The first model I estimate is one using the percentage of uninsured people by
state as the response variable to show how adopting the Medicaid expansion measures
of the ACA reduced the uninsured population, with other controls included as well. The
purpose of this model is to show if the Medicaid Expansion was successful in
significantly lowering the uninsured population, making it a reasonable treatment to
observe if increasing coverage increases overdose deaths. Then, a difference-indifferences model is constructed using the same controls, but the main variable of
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interest is the Medicaid expansion variable, which shows how the opioid overdose death
rate is affected by the adoption of Medicaid expansion. Another regression shows the
interactions between years and states in the expansion group, to show how the
difference in overdose deaths between the expansion group and non-expansion group
changes over time with respect to the adoption of the affordable care act. Each
regression is run while controlling for state and year fixed effects and log-opioid
overdose rate is used as the response variable for each regression other than the
percent uninsured regression. Absent policy differences, expansion and non-expansion
states have similar upward trends for opioid overdose deaths before the expansion of
Medicaid, making non-expansion states a reasonable control group. Also, it is assumed
there are no major changes that take place outside of Medicaid expansion during this
time in expansion or non-expansion states that are not controlled for.
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Table 2: Treatment Group Assignments

Results
The results from the first regression model are presented in Table 3, showing the
expected negative and significant coefficient on the Medicaid expansion variable both
with and without controls included, as well as significant coefficients on several of the
control variables, showing their relevance in the next regression models with overdose
deaths as the response variable. The results show that expanding Medicaid is
associated, on average, with a decrease of about 1.4 in the percentage of people

11

without health insurance, which is consistent with previous estimates and data on the
Affordable Care Act, as well as the overall goal of the act (U.S. Department of Health
and Human Services, 2021).
The results of the difference-in-differences model with log(overdoses) as the
response variable mentioned previously are presented in Table 4, with and without
controls, with the second column using only data from 2010 to 2017 to replicate results
from the paper by Averett, Smith, and Wang (2019). The Medicaid expansion coefficient
for the regression using only 2010 to 2017 data is slightly lower with a higher standard
error, showing that using fewer years in the analysis may lead to a lower and less
precise estimate of the Medicaid expansion coefficient. The regression using the full
range of data shows a significant and positive coefficient on the Medicaid expansion
variable, as well as a positive and significant coefficient on the medical marijuana
dummy variable, showing there is some evidence the Affordable Care Act led to about
15.4% higher overdose deaths in expansion states than if they had not expanded
Medicaid. The summary statistics show a 58.8% increase in opioid overdoses in
expansion states before and after Medicaid expansion, meaning about one-fourth of this
increase can be attributed to Medicaid expansion. The magnitude of this coefficient is
larger than in the previous study, which had coefficients around 10%, consistent with
the replication presented in Table 4.
Figure 1 shows the raw data using the average opioid overdose death rates in
each year for both the expansion states and non-expansion states, showing the
different patterns of overdose growth in the 2 groups, with both groups having similar
numbers of overdoses, conditional on controls, before the Affordable Care Act, but
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expansion states having significantly higher rates of overdoses after the Affordable Care
Act. Figure 2 shows the year*expansion interaction dummies using 2014 as a base
year, illustrated by the vertical red line. The graph shows positive and significant
coefficients from 2016 to 2019, showing expansion states had significantly higher opioid
overdose in those years than states that didn’t expand, likely because of the adoption of
Medicaid expansion in 2014. It is worth noting the insignificant coefficients in years prior
to 2014, showing the lack of differences in overdoses pre-expansion and implying that
the two groups had similar trajectories for opioid overdoses before the policy changes.
The coefficients being significant in 2016 through 2019 is consistent with what
one would expect, since it would take time for the policy to be implemented and utilized,
so the effects on opioid overdoses would not be felt for a couple years after the initial
implementation. This time lag could be explained by several theories. A potential cause
of increased overdoses is easier and more frequent access to opioids through
healthcare providers, leading to new addictions and eventually, more overdose deaths.
This would likely take some time to show an effect, since people would need to enroll in
the new healthcare plan, gain an opioid prescription, get addicted, and eventually
overdose. This is a relatively simple economic explanation, since lowering the cost of
acquiring opioids leads to a greater quantity demanded, and given the highly addictive
nature of opioids, a greater number of addictions. These addictions can worsen over
time, leading to overdoses or addictions to more dangerous, synthetic opioids, which
can ultimately lead to death, explaining the time lag between expanding Medicaid and
the increase in overdose deaths. Another possibility, to be explored by further study, is
moral hazard associated with increased treatment, as people act more recklessly and

13

overdose more frequently since they know there is treatment available when they
overdose. This would likely have a more immediate effect on overdoses, which could
potentially explain the slight increase in the 2015 year*expansion coefficient, but this is
not certain.
Table 3: Diff-in-Diff Showing Effect of Medicaid Expansion on Uninsured
Population
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Table 4: Diff-in-Diff Showing Effect of Medicaid Expansion on Opioid Overdoses
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Figure 2: Expansion Group Time Interaction Coefficients
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Limitations and Extensions
Like any model attempting to establish causality, the model is limited by the
potential for other confounding variables which could be leading to upward bias in the
Medicaid expansion coefficient as they could be correlated with both opioid overdoses
and the expansion of Medicaid, like specific treatment access variables which are not
readily available in the data, like variables for naloxone access laws and prescription
drug monitoring programs, both of which were used by Averett, Smith, and Wang
(2019). This could potentially lead to a higher estimate than is actual. One could
potentially include more controls for urbanicity, politics, or other variables that may be
linked to both opioid overdoses and the rate at which people are insured, but the
Medicaid expansion coefficient seems to be robust, not changing tremendously when
more controls are introduced to the model, since many of these controls are not
16

changing differently for treatment states post-expansion. This paper also only looks at
states which adopted the Medicaid expansion in 2014, not states that expanded
Medicaid before or after the 2014 adoption of the Affordable Care Act. Further study to
better corroborate or refute previous literature could use treatment groups for each
adoption time over a longer time frame, giving more observations to yield more reliable
results. A more detailed paper might also use more detailed data at the county or
individual level to control for characteristics and risk-factors at the individual level, like
gender, age, health measures, etc.
Conclusion
The expansion of Medicaid can have an unclear effect on opioid overdose
deaths, as it provides easier access to opioids for many at-risk groups but also
increases the availability of treatment options. Based on the results of this paper, I find
that Medicaid expansion in the Affordable Care Act led to significantly higher opioid
overdose death rates in states that implemented the measure, with a larger magnitude
than previously studied. This result contradicts the findings of Averett et al. who found
no significant increase or decrease in opioid mortality related to the Affordable Care Act.
This difference can be attributed to the increased data accumulated after the passage of
the Affordable Care Act, which provides more insight into the lasting effects of the act
years after passage. There are also differences in controls, as Averett et al. included
treatment option controls for Naloxone laws and prescription drug monitoring programs,
for which the data was unavailable for use in this paper, but the results of the
regressions seem to be robust as the coefficients do not change to a large degree with
or without the inclusion of several similar controls. Nonetheless, this paper finds
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sufficient evidence to conclude that the Affordable Care Act has led to a greater number
of opioid overdose deaths from increased and easier access to opioids, with the effects
setting in a few years after its implementation.
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